» Authors » A Shouzu

A Shouzu

Explore the profile of A Shouzu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 210
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Inami N, Nomura S, Shouzu A, Omoto S, Kimura Y, Takahashi N, et al.
Pathophysiol Haemost Thromb . 2008 Mar; 36(1):1-8. PMID: 18332608
The effects of treatment with pitavastatin on inflammatory and platelet activation markers and adiponectin in 117 patients with hyperlipidemia were investigated to determine whether pitavastatin may prevent the progression of...
2.
Nomura S, Inami N, Kimura Y, Omoto S, Shouzu A, Nishikawa M, et al.
J Hum Hypertens . 2006 Oct; 21(1):38-44. PMID: 17051237
Nifedipine, a dihydropyridine calcium antagonist, improves endothelial function in patients with hypercholesterolaemia by enhancing nitric oxide (NO) activity, and increases endothelial NO bioavailability by antioxidant mechanisms. We administered a long-acting...
3.
Nomura S, Shouzu A, Omoto S, Matsuzaki T, Yamaoka M, Abe M, et al.
Int J Immunogenet . 2006 Apr; 33(2):117-22. PMID: 16611256
We examined the genetic status of human leucocyte antigens (HLA), human platelet alloantigens (HPA) and neutrophil-specific antigens (NA) in patients with type 2 diabetes mellitus and diabetic arteriosclerosis obliterans (ASO)....
4.
Nomura S, Shouzu A, Omoto S, Nishikawa M, Iwasaka T
J Hum Hypertens . 2005 Apr; 19(7):551-7. PMID: 15829999
We investigated the effects of long-term benidipine treatment on levels of monocyte and endothelial cell activation markers in hypertensive patients with (n = 28) and without (n = 10) type...
5.
Omoto S, Nomura S, Shouzu A, Nishikawa M, Fukuhara S, Iwasaka T
Diabetologia . 2002 May; 45(4):550-5. PMID: 12032632
Aims/hypothesis: The role of plasma monocyte-derived microparticles (MDMPs) and platelet-activation markers (platelet-derived microparticle [PDMP], platelet-bound CD62P [plt-CD62P], and platelet-bound CD63 [plt-CD63]) in diabetic vascular complications is not clear. We measured...
6.
Nomura S, Shouzu A, Omoto S, Nishikawa M, Fukuhara S
Clin Exp Immunol . 2000 Sep; 121(3):437-43. PMID: 10971508
Levels of platelet-derived microparticles (PMPs), platelet activation markers (P-selectin expressed on, or annexin V binding to, platelets (plt:P-selectin or plt:annexin V, respectively)), chemokines (IL-8, monocyte chemotactic peptide-1 (MCP-1), and regulated...
7.
Hayakawa T, Shouzu A, Nishikawa M, Miyake Y, Shimizu H, Omoto S, et al.
Arzneimittelforschung . 2000 Aug; 50(6):535-8. PMID: 10918946
Serum thrombomodulin (TM) levels were determined in diabetic patients, and the effects of diabetic complications and renal function on TM were studied. Serum TM levels increased in diabetics, and patients...
8.
Shouzu A, Nomura S, Hayakawa T, Omoto S, Shimizu H, Miyake Y, et al.
Clin Appl Thromb Hemost . 2000 Jul; 6(3):139-43. PMID: 10898273
We measured platelet-derived microparticles, activated platelets, and various adhesion molecules in 48 patients with diabetes mellitus. We also performed a comparative study of these parameters before and after administration of...
9.
Shimizu H, Shouzu A, Nishikawa M, Omoto S, Hayakawa T, Miyake Y, et al.
Ann Clin Biochem . 1999 Dec; 36 ( Pt 6):749-54. PMID: 10586312
We measured serum and urinary 1,5-anhydro-D-glucitol (1,5-AG) during a glucose tolerance test (GTT) in patients with chronic renal failure (CRF) and compared the fractional excretion of 1,5-AG (FEAG) with that...
10.
Nishikawa M, Takagi T, Yoshikawa N, Shouzu A, Murakami T, Kono M, et al.
Clin Nephrol . 1999 Jun; 51(5):296-303. PMID: 10363630
Background: Leptin, the product of the obese gene, is produced exclusively in fat cells. Subjects, Materials And Methods: To evaluate the clinical significance of measuring serum leptin in 56 patients...